TrialScope is part of Informa Pharma Intelligence, a division of Informa Business Intelligence, Inc. (IBI). IBI is a wholly-owned subsidiary of Informa PLC.

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

TrialScope to Participate in Patients as Partners Conference


March 6, 2019

TrialScope to Participate in a Panel Discussion

at 6th Annual Patients as Partners Conference

Chief strategy officer to address the topic of clinical trial patient data
 and the impact of returning results

Jersey City, NJ – March 6, 2019 – TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that its Chief Strategy Officer, Thomas Wicks, will participate in the Partners as Patients conference March 11-12 at the Wyndham Philadelphia Historic District in Philadelphia. The panel, titled “How to Return Data to Patients and Inform Patients Throughout Trials,” is scheduled for 5 p.m. ET March 11 and will be moderated by Craig Lipset, Pfizer’s head of Clinical Innovation. Wicks will address a variety of key clinical trial data issues, such as patient preferences and concerns, the timing and “how” of data return, and ways to measure success.  

“As an industry, it’s important we acknowledge the contributions that clinical trial patients provide to advance science,” explains Wicks. “Involving patients throughout the entire trial process can not only drive greater efficiencies, but it’s being recognized by our industry sponsor clients as the ethical thing to do. At TrialScope, we’re committed to providing solutions that engage trial participants by improving the entire experience, from helping them find a study to sharing plain-language summaries. I am proud to participate in a panel, alongside my peers, at an event that truly values the patient.”

During the panel, Wicks and his colleagues will explore:

  • Patient Preferences and Concerns 
  • Timing for Data Return
  • The “How” of Data Return 
  • Goals and Success Criteria 

Patients as Partners is the only conference that puts the patient voice on the same level as industry and government in finding solutions to engage and empower patients in the clinical trial process. Speakers will demonstrate how to involve patients throughout the entire medicine development lifecycle to drive greater efficiencies in clinical research. The conference hosts clinical trial leaders from the pharmaceutical industry, patient advocacy and governmental entities.

For more information on the Patients as Partners Conference, and the full agenda, visit:

About TrialScope 
TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit